Tennis Elbow Treatment Market Size

Tennis Elbow Treatment Market Analysis

The tennis elbow treatment market is expected to register a CAGR of 4.1% during the forecast period.

During the COVID-19 pandemic, the tennis elbow treatment market encountered a setback due to the imposed lockdown, deferral, and cancellation of a range of sports events that led to a decline in sports and related other injuries. In March 2020, Tokyo Olympics and Paralympics were postponed to 2021 by the International Olympic Committee. Similarly, an article published in February 2022 recorded around a 34.6% decrease in sports-related emergency department visits in 2020. In addition, as per the same source, the majority of the sports-related ED visits were of patients aged 22 years (55.7%). Such incidents negatively impacted market growth. The medical professionals and specialists were instructed to address only the emergency and critical surgical operations during this period.

All these factors have affected product sales with declined hospital visits during the initial phases of the pandemic. Additionally, the manufacturing of tennis elbow pharmaceuticals was also affected during the first wave of the pandemic, which negatively impacted market growth in 2020.

However, in 2021, the tennis elbow treatment industry showed a sturdy recovery, owing to an increasing relaxation in restrictions leading to a rise in the number of sports activities globally. As per the data published by the NSC Injury Facts, in July 2021, the prevalence of sports and recreational injuries increased by 20% in the year 2021. Thus, the increasing number of sport-related injuries among the population is expected to increase the market growth over the forecast period. This is expected to grow further in the upcoming years.

The rising burden of sports-related and tennis elbow injuries is the key factor driving the market growth. For instance, as per an article published in February 2022, about 8.6 million athletes suffer from sports-related injuries each year in the United States. As per the data published by the NSC Injury Facts, in July 2021, about 3.2 million people received treatment in the emergency department for injuries involving sports and recreational equipment such as exercise, cycling, and basketball. This is expected to increase the risk of tennis elbow injuries, which is anticipated to increase the demand for effective treatment, propelling market growth.

Additionally, an article published in BMC Sports, Science, Medicine and Rehabilitation in January 2022 found that the administration of hyaluronic acid in patients suffering from tennis elbow has reduced the pain within three months. Thus, the use of hyaluronic acid injection is considered the best option for treating tennis elbow pain as compared to surgery and other treatment options. This is anticipated to boost market growth over the forecast period.

The rising geriatric population is also expected to increase the market growth. For instance, as per an article published in NCBI in August 2022, elderly people are at high risk of elbow injuries and traumatic fractures. The symptoms of tennis elbow usually appear at the age of 40 to 60 years. Also, as per 2022 statistics published by UNPFA, about 64% of the population living in Germany was between the ages 15-64 years in 2022, and 22% of the population was aged 65 years and above in 2022. Thus, the high number of elderly people living in the country is expected to develop elbow-related injuries as the muscles are more susceptible to overuse in middle and older age. This is anticipated to fuel the demand for effective treatment options and hence boost the market growth.

However, the sluggish commercialization of new effective therapies is expected to hamper the market growth over the forecast period.